Mazur Leonard L 4
4 · CITIUS ONCOLOGY, INC. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Mazur Leonard L
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+800,000→ 800,000 totalExercise: $1.07Exp: 2034-12-12→ Common Stock (800,000 underlying)
Holdings
- 3,700,000
Stock Option (Right to Buy)
Exercise: $2.15Exp: 2033-07-05→ Common Stock (3,700,000 underlying)
Footnotes (2)
- [F1]These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services Continuous Service to the Company as of each such vesting date.